Revance Therapeutics Inc. buy melinda
Start price
28.11.20
/
50%
€19.50
Target price
28.11.21
€23.00
Performance (%)
-36.41%
End price
01.11.21
€12.40
Summary
This prediction ended on 01.11.21 with a price of €12.40. Massive losses of -36.41% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Revance Therapeutics Inc. | - | - | - | - |
iShares Core DAX® | 1.662% | 4.835% | 17.361% | 19.329% |
iShares Nasdaq 100 | 0.667% | 0.000% | 38.234% | 55.157% |
iShares Nikkei 225® | -2.139% | -4.786% | 13.099% | 7.393% |
iShares S&P 500 | 0.564% | 0.775% | 29.181% | 46.527% |
According to melinda what are the pros and cons of Revance Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Revance Therapeutics Inc. diskutieren
Buy mit Kursziel 23,0
In the thread Trading Revance Therapeutics Inc.
Buy beendet
Stopped prediction by melinda for Revance Therapeutics Inc.
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.40
01.11.21
01.11.21
€15.00
01.11.22
01.11.22
79.03%
02.11.22
02.11.22
Could be worthwhile Investment >10% per year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.40
09.02.20
09.02.20
-
04.11.21
04.11.21
-20.08%
28.11.20
28.11.20
Could be worthwhile Investment >10% per year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.22
09.02.20
09.02.20
-
09.02.20
09.02.20
-
09.02.20
09.02.20
Could be worthwhile Investment >10% per year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.22
09.02.20
09.02.20
-
09.02.20
09.02.20
-
09.02.20
09.02.20
Could be worthwhile Investment >10% per year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€23.40
07.02.20
07.02.20
-
09.02.20
09.02.20
4.27%
09.02.20
09.02.20
Could be worthwhile Investment >10% per year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€26.38
10.05.18
10.05.18
€30.04
08.11.18
08.11.18
-17.74%
08.11.18
08.11.18
Could be worthwhile Investment >10% per year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€26.38
10.05.18
10.05.18
€30.04
10.05.18
10.05.18
0.00%
10.05.18
10.05.18
Could be worthwhile Investment >10% per year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€20.20
21.05.17
21.05.17
€23.00
26.05.17
26.05.17
6.19%
26.05.17
26.05.17
Could be worthwhile Investment >10% per year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€18.22
21.05.17
21.05.17
€20.75
26.05.17
26.05.17
6.19%
26.05.17
26.05.17
Could be worthwhile Investment >10% per year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€15.47
10.05.16
10.05.16
€17.14
24.05.16
24.05.16
11.20%
24.05.16
24.05.16
Could be worthwhile Investment >10% per year